Revised intimation of Earnings Conference Call for the quarter Q4 of FY26.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has issued a revised intimation about its earnings conference call for the fourth quarter of FY26. The call is scheduled for Wednesday, 10th June 2026 at 11:00 a.m. Investors and analysts can join via the provided Diamond Pass registration link or through the universal dial-in numbers. The call will be led by Mr. Fredun Medhora, Managing Director, with Kirin Advisors facilitating the event. This is a routine scheduling update and does not change the substance of the upcoming Q4 results discussion.
No direct impact on shareholders or stock price — this is a logistical update for an upcoming earnings call where Q4 FY26 results are likely to be discussed. Investors should watch the call for guidance, margin commentary, and any forward-looking statements from management.